Between 2003 and 2005 the largest members of PhRMA sponsored a research, policy and advocacy, and legislative effort to advance legislation to remove drug related personal injury lawsuits from the tort system into a national injury compensation program. As part of the initiative, experts at The Brattle Group estimated the total costs of drug-related injury litigation in the US and modeled the impact of the proposed legislation on those costs. The analysis included an assessment of the relative efficiency and efficacy of the compensation program.